Asceneuron
0 followers
‌
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
Industries
+1
Headquarters
Employees
Links
Org chart
Barbara Angehrn Pavik
Chief Executive Officer
Barbara Angehrn Pavik
Collapse
Sandra Millet
Head Of Operations
Matthew Foy
Investor
Eric Yuen
Scientific Advisory Board Member
Hakan Goker
Board Director And Previous Acting CBO &observer
Andrin Cerletti
Head Of Business Development
Abbas Hussain
Chairman
